Holy Basil (Tulsi)
SupplementThe medical_score (58) is lower than the community_score (72), as clinical studies [s1, s2, s3] show consistent but moderate effect sizes and safety concerns (estragole) [s9] are taken into account, while community users [c1, c2] subjectively perceive stronger and broader effects, which is typical for adaptogens with high placebo sensitivity.
Unlock full information
Dosages, side effects, studies and more — free after registration.
Register for freeRating Scales
TL;DR
Tulsi (Holy Basil) shows consistent stress-reducing and cognitive effects across three RCTs, but the evidence is limited by small sample sizes (n=40–158), short durations, and varying extracts. As a mild adaptogen with a good tolerability profile, it's a reasonable addition for everyday stress management — just don't conflate it with pharmacologically stronger adaptogens. Notably, the estragol content has prompted European authorities to caution against long-term use, and safety data beyond 8 weeks are simply absent. Standardized extracts (≥3% ursolic acid) are more reliable than tea preparations or leaf powder.
Description
Adaptogenic Ayurvedic herb with stress-reducing, anti-inflammatory, and immunomodulatory effects; moderate clinical evidence from several small RCTs [s1, s2, s3].
Holy Basil (Ocimum tenuiflorum / Ocimum sanctum), known in Sanskrit as Tulsi, is a plant native to India belonging to the mint family (Lamiaceae). In traditional Ayurvedic medicine it has been used for millennia as an adaptogen, tonic, and medicinal herb [s4]. Modern research has identified a range of bioactive constituents: eugenol, ursolic acid, rosmarinic acid, and β-caryophyllene are considered the primary active compounds [s5, s6]. Clinical human studies show consistent, albeit mostly moderate, effects on stress reduction. A double-blind, placebo-controlled RCT (n=158) using a standardized Ocimum tenuiflorum extract (Holixer™, 400 mg/day for 8 weeks) demonstrated significantly lower salivary cortisol, salivary amylase, and hair cortisol concentrations compared to placebo [s1]. A further RCT (n=150) with OciBest® (1200 mg/day for 6 weeks) showed improvements in stress-related complaints [s2]. A placebo-controlled study (n=40) on cognition in healthy adults found significant improvements in reaction time and error rate in cognitive tests [s3]. The systematic review by Jamshidi & Cohen (2017) analyzed 24 human studies on Tulsi with effects across three main areas: metabolic disorders (15 studies), cognition and mood (4 studies), and immunity and infections (5 studies) [s4]. The overall safety profile is described as favorable; however, long-term data beyond 8 weeks are lacking. The estragole content in some Tulsi products is assessed by the BfR and European authorities as a potential health risk with long-term use [s9].
Legal Status (DE)
{'efsa_health_claims_on_hold': True, 'efsa_source_ids': ['s13'], 'bfr_article8_priority_source_ids': ['s11'], 'estragol_warning_source_ids': ['s12']}
Mechanism of Action
The adaptogenic and stress-reducing properties of Tulsi are based on several complementary mechanisms: 1. HPA axis modulation: Eugenol and ursolic acid influence the hypothalamic-pituitary-adrenocortical axis and reduce cortisol secretion during stress, as demonstrated by significantly lower hair and salivary cortisol levels in the Holixer™ RCT [s1]. 2. Sympathoadrenal inhibition: Tulsi extract also reduced salivary amylase concentration in the same RCT, a marker of sympathoadrenal medullary activity, indicating attenuation of the sympathetic nervous system [s1]. 3. Immunomodulation: Eugenol, ursolic acid, and rosmarinic acid promote macrophage phagocytosis and modulate immune cell functions [s6]. This effect is supported primarily by in vitro and animal studies. 4. Anti-inflammatory action: Eugenol inhibits COX enzymes (cyclooxygenase) and reduces prostaglandin synthesis, comparable to the mechanism of NSAIDs such as ibuprofen, but with lower potency [s5]. 5. Cognitive modulation: Animal and human studies suggest improvement of cholinergic transmission and an antioxidant neuroprotective effect, which may contribute to the observed improvements in reaction time and cognitive accuracy [s3, s4].
Dosing
Stressreduktion (standardisierter Extrakt)
- Dose
- 400 mg standardized Ocimum tenuiflorum extract (Holixer™)
- Frequency
- 1× täglich
- Route
- oral
- Duration
- 8 Wochen
- Timing
- Morning with meal
- With food
- empfohlen
Allgemeine Stressreduktion (OciBest®-Extrakt)
- Dose
- 1200 mg Ocimum tenuiflorum extract (OciBest®)
- Frequency
- aufgeteilt auf 2–3 Dosen täglich
- Route
- oral
- Duration
- 6 Wochen
- Timing
- With meals
- With food
- empfohlen
Kognitive Funktion (Blattextrakt)
- Dose
- 300 mg ethanolic leaf extract
- Frequency
- 1× täglich
- Route
- oral
- Duration
- 30 Tage
- Timing
- With meal
- With food
- empfohlen
Allgemeine adaptogene Unterstützung (Blattpulver)
- Dose
- 1000–2500 mg leaf powder
- Frequency
- 1–2× täglich
- Route
- oral
- Duration
- fortlaufend, max. 8 Wochen Langzeitdaten verfügbar
- Timing
- With meals
- With food
- empfohlen
No officially established maximum daily dose exists. Clinical studies used up to 1200 mg/day extract for 6–8 weeks [s1, s2]. Long-term data beyond 8 weeks are lacking [s8]. Due to estragole content, European authorities recommend limiting intake [s9].
Dosages vary considerably depending on extract type (leaf powder vs. standardized extract vs. tea). Standardized extracts for ursolic acid (≥3%) or triterpenes (≥30 mg) are considered more reliable in effect [s7]. No established safe long-term dose.
Side Effects
| Side Effect | Frequency | Severity |
|---|---|---|
| Übelkeit, Durchfall, leichte gastrointestinale Beschwerden Occasionally reported in clinical trials and case reports; typical at higher doses [s8]. | gelegentlich | leicht |
| Leichte Verstopfung (bei Gesamtextrakt) Known from traditional use and review literature; rarely observed in controlled studies [s4]. | selten | leicht |
| Potenzielle karzinogene Wirkung durch Estragol bei Langzeitanwendung BfR and European authorities classify estragole as potentially carcinogenic and mutagenic. Relevance at typical supplement doses is unclear, but flagged as a regulatory priority [s9]. | theoretisch | schwer |
| Erhöhte Blutungsneigung Eugenol inhibits platelet aggregation; increased bleeding risk with concomitant anticoagulant use is theoretically possible [s5, s8]. | theoretisch | moderat |
| Hypoglykämie (Blutzuckersenkung) Animal experimental evidence for blood glucose-lowering effects; theoretical risk of hypoglycemia in diabetic patients on pharmacological therapy [s4]. | selten | moderat |
| Schilddrüsenhormon-Modulation Possible influence on thyroid function described in case reports and animal studies; not confirmed in controlled human studies [s8]. | theoretisch | moderat |
Contraindications
Animal experimental evidence of uterotonic activity; potential risk of preterm labor or miscarriage. Use during pregnancy not recommended [s5, s8].
Eugenol inhibits platelet aggregation; increased bleeding risk. Discontinue at least 2 weeks before planned procedures [s5].
Possible interaction with thyroid function based on animal studies and case reports; clinical relevance in humans unclear [s8].
Additive blood glucose lowering possible; risk of hypoglycemia with combined use. Medical consultation recommended [s4].
Safety data on use during lactation are lacking; use not recommended [s8].
Interactions
Synergistic
Tulsi and Rhodiola are frequently combined as complementary adaptogens. Both modulate the HPA axis and may jointly improve stress resilience.
The combination of Tulsi and Bacopa monnieri is used in adaptogen complexes. Bacopa supports memory and cognition, while Tulsi regulates the stress response.
Tulsi and Cordyceps are used in combined adaptogen formulas. Both act as adaptogens and support the immune system via distinct mechanisms.
Tulsi and Ashwagandha complement each other well as adaptogens. Ashwagandha actively lowers cortisol levels and supports sleep, while Tulsi improves mood, cognition, and systemic stress adaptation.
Tulsi and Panax ginseng are used together in adaptogen complexes. Both act as adaptogens via distinct phytochemical constituents and may jointly support stress resilience and mental performance.
Tulsi and Schisandra both appear in adaptogen complex formulas. Both modulate the HPA axis and may jointly improve resilience to physical and mental stress.
Caution
Holy basil (Ocimum tenuiflorum) may additively potentiate the hypoglycemic effect of metformin through its demonstrated blood glucose-lowering properties, presumably via improved insulin sensitivity and inhibition of gluconeogenesis. Close blood glucose monitoring is recommended during concomitant use to avoid hypoglycemia.
Tulsi may lower thyroxine levels and worsen pre-existing hypothyroidism. Tulsi should be used with caution in hypothyroidism or iodine deficiency.
Both Tulsi and berberine have blood glucose-lowering properties. The combination may act additively and increase the risk of hypoglycemia.
Both substances have anti-inflammatory properties via partially overlapping mechanisms (NF-κB inhibition). Combination is generally possible but should be approached cautiously at high doses, as additive effects on blood coagulation cannot be excluded.
Studies
Tier A — High Evidence
Outcome: Stress-related symptom reduction (OciBest® 1200 mg/day)
Effect Size: Significant improvements in stress symptoms vs. placebo (exact effect size not extractable from search context)
Outcome: Cognitive parameters: reaction time and error rate (Sternberg test, Stroop test)
Effect Size: Significant improvements in RT and ER vs. placebo across multiple cognitive tests
Outcome: Stress reduction (MAST score), cortisol parameters (salivary and hair cortisol), salivary amylase, blood pressure
Effect Size: Significantly lower salivary cortisol, sAA, and hair cortisol values vs. placebo; p-values not extractable from full text
Tier B — Moderate Evidence
Outcome: Clinical efficacy and safety of Tulsi in humans across all indications
Effect Size: Consistent evidence for adaptogenic, anti-diabetic, and immunomodulatory effects; methodological quality varies
Tier C — Low Evidence
Outcome: Immunomodulatory activity of eugenol, ursolic acid, and rosmarinic acid
Effect Size: Promotion of macrophage phagocytosis; not directly transferable to humans
Community Evidence
Top reported benefits
- Noticeable reduction of everyday stress and anxiety
- Improved focus and clearer thinking
- Mild, pleasant effect without sedation
- Good tolerability without gastrointestinal complaints
- Positive combination with other adaptogens
Top reported issues
- No perceptible effect in some users
- Effect difficult to distinguish from placebo
- Unclear dosing across different product forms (tea vs. capsule)
- Tea taste perceived as intense/peppery
Some users report inconsistent effects depending on product and extract quality. Community discussions mention concerns regarding product quality and standardization. Estragole content is occasionally discussed as a safety topic in German-language forums [s9]. Effects are predominantly described as mild; expectations based on traditional accounts are not always met.
Scientific Sources
- A randomized, double-blind, placebo-controlled trial investigating the effects of an Ocimum tenuiflorum (Holy Basil) extract (HolixerTM) on stress, mood, and sleep in adults experiencing stress
Lopresti AL, Smith SJ, Rao A, et al. (2022). Frontiers in NutritionAPMID:36185698DOI - Novel Food Status Catalogue und Regulation (EU) 2015/2283 – Pflanzliche Nahrungsergänzungsmittel
European Commission Food Safety Unit (2023). European Commission – Food SafetyALink - First Report of the HoA Working Group 'Food Supplements' – Priority Botanicals incl. Ocimum tenuiflorum
["BVL/BfR Heads of Agencies (HoA) Working Group Food Supplements"] (2024). CLink - Gehalte an Cumarin, Safrol, Methyleugenol und Estragol in Lebensmitteln (insbesondere in teeähnlichen Erzeugnissen)
["Bundesinstitut für Risikobewertung (BfR)"] (2002). CLink - Botanicals – EFSA Compendium of Botanicals (4th edition, 2024)
["European Food Safety Authority (EFSA)"] (2024). CLink - Efficacy of an Extract of Ocimum tenuiflorum (OciBest) in the Management of General Stress: A Double-Blind, Placebo-Controlled Study
Bhattacharyya D, Sur TK, Jana U, et al. (2012). Evidence-Based Complementary and Alternative MedicineADOI - Holy basil (Ocimum sanctum Linn.) leaf extract enhances specific cognitive parameters in healthy adult volunteers: A placebo controlled study
Sampath S, Mahapatra SC, Padhi MM, et al. (2015). Journal of Traditional and Complementary MedicineAPMID:26571987DOI - The Clinical Efficacy and Safety of Tulsi in Humans: A Systematic Review of the Literature
Jamshidi N, Cohen MM (2017). Evidence-Based Complementary and Alternative MedicineADOI - Therapeutic uses of Ocimum sanctum Linn (Tulsi) with a note on eugenol and its pharmacological actions: a short review
Prakash P, Gupta N (2005). Indian Journal of Physiology and PharmacologyBPMID:16170979 - Harnessing the Antibacterial, Anti-Diabetic and Anti-Carcinogenic Properties of Ocimum sanctum Linn (Tulsi)
Arya V, Gupta VK, Kaur R, et al. (2024). Plants (MDPI)BDOI - Holy Basil (Tulsi): Benefits, Forms, Dosing, and Side Effects
Stanfield B (2024). drstanfield.com (narrative review)CLink - Holy Basil (Indisches Basilikum) – Nebenwirkungen, Wechselwirkungen, Sicherheit
MSD Manual Editors (2023). MSD Manual Profi-Ausgabe / PatientenausgabeBLink - Rein pflanzlich heißt nicht immer harmlos – Risikobewertung botanischer Stoffe in Nahrungsergänzungsmitteln
Verbraucherzentrale Deutschland (2023). Verbraucherzentrale.deBLink
Community Sources
Storage
Unopened
Store dry, cool, and protected from light at room temperature.
Opened
Keep container tightly closed; avoid moisture and direct sunlight.
Notes
Store extracts and capsules according to manufacturer instructions; leaf powder is particularly sensitive to moisture.